Antibacterial and regenerative action of fibrin rich in platelets and leukocytes

Main Article Content

Bruna Somilio da Fonseca
Jorge Alberto Achcar
Fernanda de Freitas Aníbal
Wilton Rogério Lustri
André Capaldo Amaral

Abstract

Introduction: Regenerative medicine involves, among other biostimulating strategies, the use of blood derivatives in order to regulate and accelerate the healing process. Fibrin rich in platelets and leukocytes (L-PRF) is a resultant platelet with 3 by-products: acellular supernatant serum (SAS), clot and exudate. Despite being promising, there are few studies that characterize the real influence of this platelet concentrate on the repair of cutaneous wounds. Objective: To evaluate, within an in vitro investigative approach, through antibacterial analysis and cytokine and growth factor dosage, the immunomodulatory influence of L-PRF. Method: 10 clinically healthy volunteers were selected. Some women practiced physical activity daily and others weekly. To obtain the L-PRF derivatives, a blood sample was collected, with the amount of 4 tubes of 5 mL of blood from each candidate. Results: The evaluation of the potential antibacterial properties of the volunteers, on Staphylococcus aureus and Pseudomonas aeruginosa, showed positive action in 40% of the total L-PRF by-products. There was selectivity and differentiation, in the intrinsic individuality of each volunteer, when comparing the 3 elements of L-PRF in the inhibition of the growth zone. Then came another stage of the present study, the dosage of cytokines and growth factor, respectively: tumor necrosis factor (TNF), interleukin 10 (IL-10) and transforming growth factor b (TGF-β) in SAS and exudate. Conclusion: In view of the determination of the antibacterial effect of the by-products of L-PRF, exudate and clot, promising results are also evident, in relation to the biomodulatory effect evidenced in this last step, when comparing the SAS and exudate.

Downloads

Download data is not yet available.

Article Details

How to Cite
Somilio da Fonseca, B., Alberto Achcar, J. ., Freitas Aníbal, F. de ., Rogério Lustri, W. ., & Capaldo Amaral, A. . (2025). Antibacterial and regenerative action of fibrin rich in platelets and leukocytes. Revista Brasileira Multidisciplinar, 28(1), e-2025202073. https://doi.org/10.25061/2527-2675/ReBraM/2025.v28i1.2073
Section
Artigos Originais

References

AIRES, F. T.; BERNARDO, W. M. Tratamento do cisto pilonidal: cicatrização por segunda intenção ou sutura primária em linha média?. Rev. Assoc. Med. Bras., v. 55, p. 508, 2009.

BILGEN, F.; URAL, A.; BEKERECIOGLU, M. Platelet-rich fibrin: an effective chronic wound healing accelerator. J. Tissue Viability, v. 30, n. 4, p. 616-620, 2021.

CASTRO, A. B. et al. Impacto da força g e do tempo nas caracterísitcas de matrizes de fibrina rica em plaquetas. Relatórios Científicos, n. 11, p. 6038, 2021.

CHOUKROUN, J. et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., v. 101, n. 3, p. E56-60., 2006a.

CHOUKROUN, J. et al. Affiliations expandPlatelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., v. 101, n. 3, p. 299-303, 2006b.

DOHAN, D. M. et al. Gogly Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. v. 101, n. 3, p. e51-55, 2006a.

DOHAN, D. M. et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., v. 101, n. 3, p. e45-50, 2006b.

GODOI, V. R. F.; OLIVEIRA NETO, J. L.; PEREIRA, L. C.; MACEDO, C. J. O,; CORAL, A. J. Platelet and leukocyte rich fibrin (L-PRF) applied in necrotizing Fasciitis treatment: case report. Braz. J. Development. v. 8, n. 8, p. 58258-73, 2022.

JOHANSSON, D.; SHANNON, O.; RASMUSSEN, M. Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection. PloS one, v. 6, n. 11, p. e26928, 2011.

LEAL, B. P. V.; VILHENA, H. Estudo da atividade antimicrobiana da fibrina rica em plaquetas (PRF) de origem canina. 2022. Tese (Doutorado) – Escola Universitaria Vasco da Gama, 2022.

NGUYEN, P. A,; PHAM, T. A. V. Effects of platelet-rich plasma on human gingival fibroblast proliferation and migration in vitro. J. Applied Oral Science. v. 26, p. 1-9, 2018.

OUYANG, W.; RUTZ, S.; CRELLIN, N. K.; VALDEZ, P. A.; HYMOWITZ, S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol., v. 29, p. 71-109, 2011.

PEGORARO, A. F.; FREDBERG, J.; CHEN, Z. Modeling physiological events in 2D vs. 3D cell culture. Physiology, v. 32, n. 4, p. 266-277, 2017.

ROJAS, B. S. M.; DE-LA-HOZ, J. L.; FACCHINI, G.; SILVA, G. H.; PINHEIRO, A. L. T. A.; EBERLIN, S. Estudo comparativo para avaliação da eficácia cicatrizante de formulações tópicas contendo Triticum aestivum L. (sinônimo Triticum vulgare) em modelo de pele humana. Surg. Cosmet. Dermatol., v. 14, p. e20220118, jan.-dez. 2022.

SAMPOGNA, G.; GURAYA, S. Y.; FORGIONE, A. Regenerative medicine: historical roots and potential strategies in modern medicine. J. Microscopy Ultrastructure, v. 3, n. 3, p. 101-107, 2015.

SHANNON, O. Determining platelet activation and aggregation in response to bacteria. Methods Mol. Biol., v. 1535, p. 267-273, 2017.

SILVA, M. S. et al. Citocinas. ACTA MSM, n. 4, p. 205217, 2019.

TZAVLAK, K.; MOUSTAKAS, A. TGF-β Signaling. Biomolecules, v. 10, n. 3, p. 487, 2020.

XIONG, M. et al. The novel mechanisms and applications of exosomes in dermatology and cutaneous medical aesthetics. Pharmacol. Res., v. 166, p. 105490, 2021.

Most read articles by the same author(s)